The governor also said she would work with other states to leverage their combined purchasing power to reduce the cost of the ...

As the year unfolds the biotech industry will look closely at these ten first-in-class drugs on track to reach FDA approval ...

The Lancet Diabetes & Endocrinology published its Commission on the definition and diagnostic criteria of clinical obesity.

An international group of experts proposes two new categories of disease: preclinical and clinical obesity and the FDA ...

BMI has long been considered a flawed measure that can over-diagnose or underdiagnose obesity, which is currently defined as ...

But now that these drugs are in greater demand from both patients and doctors, state Medicaid programs are grappling with whether to cover them for weight loss, both for reasons of equity and to save ...

When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...

Obesity affects over 1 billion people globally, with 40 percent of U.S. adults classified as obese under the present ...

Using body-mass index to tell who is overweight or obese is not reliable and can result in misdiagnosis, the Commission on ...

Habits like getting adequate exercise, nutrition, and sleep can have profoundly positive effects on overall health whether ...

The FDA approved the phase 2 Explore-OSA trial set to assess the highly selective aldosterone synthase inhibitor, ...